Biolargo Inc (BLGO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -15,189 | -4,347 | -4,648 | -5,132 | -6,894 |
| Depreciation Amortization | 293 | 255 | 272 | 45 | 20 |
| Accounts receivable | -1,814 | -569 | -1,633 | -551 | -29 |
| Other Working Capital | -1,135 | -1,620 | -1,077 | -250 | 249 |
| Other Operating Activity | 9,548 | 3,075 | 4,721 | 3,126 | 2,717 |
| Operating Cash Flow | $-8,297 | $-3,206 | $-2,365 | $-2,762 | $-3,937 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -46 | -1,235 | -478 | -271 | -21 |
| Purchase Sale Intangibles | N/A | N/A | N/A | N/A | -13 |
| Other Investing Activity | 481 | -82 | 0 | 0 | -13 |
| Investing Cash Flow | $435 | $-1,317 | $-478 | $-271 | $-34 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | 100 | -37 |
| Debt Issued | 24 | -14 | 65 | N/A | N/A |
| Common Stock Issued | 4,791 | 3,588 | 3,046 | 3,657 | 5,096 |
| Other Financing Activity | 3,406 | 864 | 1,548 | 199 | -828 |
| Financing Cash Flow | $8,221 | $4,438 | $4,659 | $3,956 | $4,231 |
| Exchange Rate Effect | -24 | 94 | -128 | -34 | -14 |
| Beginning Cash Position | 3,548 | 3,539 | 1,851 | 962 | 716 |
| End Cash Position | 3,883 | 3,548 | 3,539 | 1,851 | 962 |
| Net Cash Flow | $335 | $9 | $1,688 | $889 | $246 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,297 | -3,206 | -2,365 | -2,762 | -3,937 |
| Capital Expenditure | -46 | -1,235 | -478 | -271 | -21 |
| Free Cash Flow | -8,343 | -4,441 | -2,843 | -3,033 | -3,958 |